Post

New research · Endocrinology
Diabetes care · 4d
Cohort studyDiabetes care · 2026

Emergency Hospitalization, Amputation, and Survival After Charcot Neuro-Osteoarthropathy Diagnosis in People With Diabetes: A Regional Registry-Based Cohort Study.

Victoria E L Milbourn, Ruth Barn, Zoë Tieges … Jaap J van Netten
Read paper
EndocrinologyCohort study

Most people with Charcot neuro-osteoarthropathy experience an emergency hospitalization.

Emergency Hospitalization, Amputation, and Survival After Charcot Neuro-Osteoarthropathy Diagnosis in People With Diabetes: A Regional Registry-Based Cohort Study.

Victoria E L Milbourn … Jaap J van Netten
Diabetes care · 2026
Purpose

The aim for this study was to describe adverse outcomes after Charcot neuro-osteoarthropathy (charcot neuro-osteoarthropathy) diagnosis in adults with diabetes and examine variation by clinical and sociodemographic characteristics.

Methods

A regional, registry-based cohort study was conducted using linked routinely collected health care data from adults with diabetes and a first recorded charcot neuro-osteoarthropathy diagnosis in the National Health Service Greater Glasgow and Clyde, Scotland (2015-2024).

n = 127,513 adults
Results

most people with Charcot foot had an emergency hospitalization

HR by subgroup · 95% CI
null = 1
lower-extremity amputation
8.52
mortality rate
3.04
More results

From 127,513 adults with diabetes, 140 individuals with a first recorded charcot neuro-osteoarthropathy diagnosis were identified; their mean age was 59 years, and 67% were men.

The estimated 5-year survival was 67%, while 5-year amputation-free survival was 44% (median 4.04 years).

More results

Advanced chronic kidney disease (stages 4 and 5) was associated with higher risk across outcomes.

“
Conclusion · 1 of 2

Adverse outcomes in charcot neuro-osteoarthropathy were frequent and occurred early after diagnosis, with high rates of emergency hospitalization, amputation, and death.

Conclusion · 2 of 2

These findings support charcot neuro-osteoarthropathy as a marker of systemic vulnerability and highlight the need for prioritized surveillance and multidisciplinary management in routine clinical care.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Cohort Study
26%
developed swelling in the eye’s central retina after the combined surgery
Cohort Study
57%
eyes could see better after three ranibizumab injections
Cohort Study
22%
eyes gained at least two lines of vision, meaning better eyesight
Cohort Study
303 ± 67 μm
Average central macular thickness was lower at 52 weeks.
Cross-sectional
MYR 88,346.12
Average annual out-of-pocket expenditure for patients with cancer in Malaysia.
Guideline
between ages 7.0 and 8.0 years
girls with early breast development for whom doctors suggest observation, not immediate tests
Cross-sectional
43%
of people using automated insulin delivery, this many had poor sleep quality